Albumin and interferon-β fusion protein serves as an effective vaccine adjuvant to enhance antigen-specific CD8+ T cell-mediated antitumor immunity
Article in Journal for ImmunoTherapy of Cancer (April 2022)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in Journal for ImmunoTherapy of Cancer (April 2022)
Article in Tumour Virus Research (December 2017)
Article in Scientific Reports (February 2016)